Topical intranasal corticosteroids in 4-11 year old children with persistent bilateral otitis media with effusion in primary care: double blind randomised placebo controlled trial
Williamson, Ian, Benge, Sarah, Barton, Sheila, Petrou, Stavros, Letley, Louise, Fasey, Nicky, Haggard, Mark and Little, Paul (2009) Topical intranasal corticosteroids in 4-11 year old children with persistent bilateral otitis media with effusion in primary care: double blind randomised placebo controlled trial. British Medical Journal, 339, (b4984), 1-8. (doi:10.1136/bmj.b4984).
Full text not available from this repository.
Objective: to determine the clinical effectiveness of topical intranasal corticosteroids in children with bilateral otitis media with effusion.
Design: double blind randomised placebo controlled trial.
Setting: 76 Medical Research Council General Practice Research Framework practices throughout the United Kingdom, between 2004 and 2007.
Participants: 217 children aged 4-11 years who had at least one practice recorded episode of otitis media or a related ear problem in the previous 12 months, and with bilateral otitis media with effusion confirmed by a research nurse using otoscopy plus micro-tympanometry (B/B or B/C2, modified Jerger types).
Intervention: mometasone furoate 50 µg or placebo spray given once daily into each nostril for three months.
Main outcome measures: proportions of children cured of bilateral otitis media with effusion assessed with tympanometry (C1 or A type) at one month (primary end point), three months, and nine months; adverse events; three month diary symptoms.
Results: 41% (39/96) of the topical steroid group and 45% (44/98) of the placebo group were cured in one or both ears at one month (difference favouring placebo 4.3% (95% confidence interval –9.3% to 18.1%). Poisson regression was done with adjustment for four pre-specified covariates (clinical severity, P=0.003; atopy, P=0.67; age, P=0.92; season, P=0.71). The adjusted relative risk at one month was 0.97 (95% confidence interval 0.74 to 1.26). At three months, 58% of the topical steroid group and 52% of the placebo group were cured (relative risk 1.23, 0.84 to 1.80). Diary symptoms did not differ between the two groups, and no significant harms were reported.
Conclusions: topical steroids are unlikely to be an effective treatment for otitis media with effusion in general practice. High rates of natural resolution occurred by 1-3 months.
|Digital Object Identifier (DOI):||doi:10.1136/bmj.b4984|
|Subjects:||R Medicine > RJ Pediatrics|
|Divisions :||University Structure - Pre August 2011 > School of Medicine > Community Clinical Sciences
|Accepted Date and Publication Date:||
|Date Deposited:||04 Mar 2010|
|Last Modified:||31 Mar 2016 13:05|
|RDF:||RDF+N-Triples, RDF+N3, RDF+XML, Browse.|
Actions (login required)